Publications by authors named "Mary Oates"

Claim this Profile
E
Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis.
E Michael Lewiecki, Donald Betah, Ludovic Humbert, Cesar Libanati, Mary Oates

JBMR Plus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.
Serge Ferrari, Donald Betah, Robert G Feldman, Bente L Langdahl, Mary Oates

J Clin Endocrinol Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab improves microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis.
Michael R McClung, Donald Betah, Benjamin Z Leder, David L Kendler, Mary Oates

J Bone Miner Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension.
Felicia Cosman, Mary Oates, Donald Betah, Jen Timoshanko, Zhenxun Wang

J Bone Miner Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstruction of remodeling units reveals positive effects after 2 and 12 months of romosozumab treatment.
Erik F Eriksen, Rogely W Boyce, Yifei Shi, Jacques P Brown, Donald Betah, Mary Oates

J Bone Miner Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate.
E Michael Lewiecki, Donald Betah, Ludovic Humbert, Cesar Libanati, Mary Oates

J Bone Miner Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial.
Nancy E Lane, Donald Betah, Cynthia Deignan, Mary Oates, Zhenxun Wang

ACR Open Rheumatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
Bente Langdahl, Lorenz C Hofbauer, Serge Ferrari, Zhenxun Wang, Astrid Fahrleitner-Pammer, Mary Oates

Osteoporos Int· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Paul D Miller, Jonathan D Adachi, Ben-Hur Albergaria, Angela M Cheung, Arkadi A Chines, Mary Oates

J Bone Miner Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical management patterns in a US commercial claims database following a nontraumatic fracture in postmenopausal women.
Xin Wang, Xiaoqing Xu, Mary Oates, Timothy Hill, Rolin L Wade

Arch Osteoporos· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab and antiresorptive treatment: the importance of treatment sequence.
Felicia Cosman, David L Kendler, Bente L Langdahl, Benjamin Z Leder, E Michael Lewiecki, Mary K Oates

Osteoporos Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosis.
Piet Geusens, Robert Feldman, Mary Oates, Thierry Thomas, Polyzois Makras

Bone· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries.
Jiannong Liu, Andrew Laster, Xiaoqing Xu, Haifeng Guo, Mary Oates

J Bone Miner Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
Jacques P Brown, Klaus Engelke, Tony M Keaveny, Arkadi Chines, Roland Chapurlat, Mary K Oates

J Bone Miner Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal responses to romosozumab after 12 months of denosumab.
Michael R McClung, Michael A Bolognese, Jacques P Brown, Jean-Yves Reginster, Bente L Langdahl, Mary K Oates

JBMR Plus· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning With Electronic Health Records for Short-Term Fracture Risk Identification: Crystal Bone Algorithm Development and Validation.
Yasmeen Adar Almog, Angshu Rai, Patrick Zhang, Amanda Moulaison, Ross Powell, Mary Oates

J Med Internet Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study.
Piet Geusens, Mary Oates, Akimitsu Miyauchi, Jonathan D Adachi, Marise Lazaretti-Castro

JBMR Plus· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on osteoporosis from the 2014 Santa Fe Bone symposium.
E Michael Lewiecki, John P Bilezikian, Neil Binkley, Didier Hans, Diane Krueger, Mary Oates

Endocr Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Product Quality: a Summary of the Second FDA/PQRI Conference.
Lawrence X Yu, Ilgaz Akseli, Barbara Allen, Gregory Amidon, Tara Gooen Bizjak, Mary Oates

AAPS J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral adipose tissue quantification using Lunar Prodigy.
David L Ergun, Megan P Rothney, Mary K Oates, Yi Xia, Wynn K Wacker

J Clin Densitom· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection scintigraphy: added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis.
Christian J Ingui, Nirav P Shah, Mary E Oates

J Comput Assist Tomogr· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis